Yeah fair enough, I think that with the Amgen deal they'll do the production for the first few product launches and then UNS will take over when they've got the cash to invest or revenues to go to the bond markets or banks to borrow money and show a profitable future
UNS Price at posting:
5.8¢ Sentiment: Buy Disclosure: Held